Section

Health

Public health, medicine, biotech

Los Angeles Times

Measles Cases in the U.S. Reach Highest Level Since 1991

The CDC has reported 2,318 measles cases in the U.S. for the year, the highest figure since the epidemic of 1989 to 1991. California is identified as a state that could be particularly vulnerable to outbreaks.

Bias: 4 Sentiment: +0.00
Los Angeles Times

Measles Cases in the U.S. Reach Highest Level Since 1991

The CDC has reported a total of 2,318 measles cases in the U.S. for the year, marking the highest number since the epidemic of 1989 to 1991. This increase highlights ongoing public health concerns regarding measles outbreaks.

Bias: 4 Sentiment: +0.00
Washington Examiner

CDC reports highest measles rates in 35 years following outbreaks

The CDC has reported a significant increase in measles cases in the U.S., with 2,318 cases recorded in the first seven months of 2026, marking a 35-year high. The rise is attributed to decreased vaccination rates, and the Pan American Health Organization is set to review the U.S.'s measles elimination status in November, which may be at risk due to the recent outbreaks.

Bias: 4 Sentiment: +0.00
Scientific American

Experts Discuss Duration of Cyclosporiasis Outbreaks

Thousands have fallen ill from cyclospora, and experts are uncertain about when the outbreaks will conclude. There is a lack of consensus among specialists regarding the situation's resolution.

Bias: 4 Sentiment: -0.10
The Daily Beast

FDA Investigates Second Cyclosporiasis Outbreak Linked to Lettuce

The FDA is currently investigating a second cyclosporiasis outbreak that has sickened 72 individuals, adding to a larger outbreak linked to lettuce from Taylor Farms affecting about 4,000 people. Health officials have not yet identified the source of the new outbreak, while the CDC reports hundreds of hospitalizations but no deaths related to the illness.

Bias: 4 Sentiment: +0.00
Al Jazeera English

US Reports 2,318 Measles Cases, Exceeding 2025 Total

The US has reported 2,318 measles cases as of July 24, 2026, exceeding the total for the previous year. Experts attribute this rise to decreasing vaccination rates, which leave young children and other vulnerable groups at greater risk.

Bias: 4 Sentiment: -0.10
PBS NewsHour

U.S. Reports Significant Increase in Measles Cases in 2026

In 2026, the U.S. has experienced a significant rise in measles cases, surpassing the total for all of 2025. Major outbreaks have occurred in South Carolina, Utah, and Arizona, with hundreds affected and smaller clusters reported in other states.

Bias: 4 Sentiment: -1.00
The Atlantic

FDA Advisory Committee Recommends Compounding of BPC-157 Peptide

An FDA advisory committee has recommended that compounding pharmacies be allowed to produce BPC-157, a peptide with limited human safety data. The decision, which passed with an 8-6 vote, aims to provide safer access to the peptide amid concerns about unregulated online sales. Other peptides were also recommended, indicating potential growth in the market for these substances.

Bias: 4 Sentiment: +0.00
Washington Examiner

CDC Expands Investigation into Cyclosporiasis Outbreak in Nine States

The CDC has expanded its investigation into a cyclosporiasis outbreak, now involving nine states, including Illinois, Kansas, Oklahoma, and Pennsylvania. The outbreak has affected 1,947 individuals, with 98 hospitalizations reported. Investigators are tracing the source of contaminated lettuce and examining additional illnesses in other states.

Bias: 4 Sentiment: +0.00
Guardian — US

CDC Investigates Cyclosporiasis Outbreak Affecting Nine States

The CDC is currently investigating a cyclosporiasis outbreak that has spread to nine states, with over 11,500 suspected cases reported this summer. The agency has confirmed 4,173 laboratory cases and is looking into an additional 7,400 cases.

Bias: 14 Sentiment: +0.00
Guardian — US

New Cyclospora Outbreak Identified in 41 States

A cyclospora outbreak has been reported in 41 states, with at least 72 cases confirmed. Officials are investigating a new cluster of cases and facing challenges related to product recalls and regulatory delays.

Bias: 14 Sentiment: -0.10
Al Jazeera English

Research on Thymus Gland and Its Role in Aging

Research is focusing on the thymus gland, which plays a role in the immune system and becomes less active with age. Scientists are investigating its potential link to longevity and health.

Bias: 4 Sentiment: +0.10
Axios

AI Experts Express Concerns Over Potential Pathogen Risks

AI experts have raised concerns about the potential for advanced AI technologies to aid in the creation of deadly pathogens. A study indicates a 12% chance of catastrophic outcomes related to AI by 2030. Leaders in the AI field have called for increased safeguards to address the risks associated with AI-derived bioweapons.

Bias: 4 Sentiment: -0.20
Fox News — Latest

Two Stabbings in NYC Investigated as Possible Hate Crimes

Two stabbings in New York City are under investigation as possible hate crimes, with the suspect allegedly yelling "Allahu Akbar" during the attacks. Both victims, one Jewish and one Asian, were hospitalized in stable condition. Officials are examining the suspect's mental health as a potential factor in the incidents.

Bias: 30 Sentiment: -0.50
Al Jazeera English

Health Workers in DRC Face Challenges Amid Ebola Outbreak

Health workers in the Democratic Republic of the Congo are facing significant challenges, including infection risks and community hostility, as they work to manage the Ebola outbreak. These issues underscore the hardships encountered by healthcare professionals in the region.

Bias: 30 Sentiment: -0.10
PBS NewsHour

FDA Advisory Panel Meeting on Peptides Continues

The FDA is conducting a two-day advisory panel meeting focused on the use of peptides. Health Secretary Robert F. Kennedy Jr. supports the use of peptides and aims to change restrictions set by the previous administration.

Bias: 4 Sentiment: +0.00
The Hill

FDA Panel Votes to Include Peptides in Compounding List

The FDA's Pharmacy Compounding Advisory Committee voted to allow compounding pharmacies to create peptides, despite opposition from agency scientists about their benefits. The decision followed a review of public comments and presentations on specific peptides.

Bias: 4 Sentiment: +0.00